El-Kurjieh A, Al-Arab R, Hachem Q, Ibrahim J, Kobeissy P
Lipids Health Dis. 2025; 24(1):74.
PMID: 40001058
PMC: 11853604.
DOI: 10.1186/s12944-025-02491-z.
Mustata M, Ionescu M, Radu L, Neagoe C, Ahritculesei R, Cimpeanu R
Diagnostics (Basel). 2025; 14(24.
PMID: 39767248
PMC: 11675552.
DOI: 10.3390/diagnostics14242887.
Lee S, Lee J, Kim H, Park J, Choi J
Antioxidants (Basel). 2025; 13(12.
PMID: 39765869
PMC: 11727202.
DOI: 10.3390/antiox13121541.
Jain H, Jain J, Dey D, Modi R, Alomari O, Ahmed M
Clin Cardiol. 2024; 47(12):e70047.
PMID: 39660694
PMC: 11632626.
DOI: 10.1002/clc.70047.
Araki K, Maeda R
Antibodies (Basel). 2024; 13(4).
PMID: 39584990
PMC: 11587137.
DOI: 10.3390/antib13040090.
Secukinumab Reduces Psoriasis-associated Pruritus and Regenerates the Cutaneous Nerve Architecture: Results from PSORITUS a Doubleblind, Placebo-controlled, Randomized Withdrawal Phase IIIb Study.
Renkhold L, Pereira M, Loser K, Metze D, Baeumer D, Melzer N
Acta Derm Venereol. 2024; 104:adv40737.
PMID: 39565228
PMC: 11600607.
DOI: 10.2340/actadv.v104.40737.
Understanding the interplay between psoriatic arthritis and gout: "Psout".
Sherri A, Mortada M, Makowska J, Sokolowska M, Lewandowska-Polak A
Rheumatol Int. 2024; 44(12):2699-2709.
PMID: 39441397
PMC: 11618146.
DOI: 10.1007/s00296-024-05729-8.
Sphingosine 1-phosphate receptor 2 in keratinocytes plays a key role in reducing inflammation in psoriasis.
Masuda-Kuroki K, Alimohammadi S, Lowry S, Di Nardo A
Front Immunol. 2024; 15:1469829.
PMID: 39391307
PMC: 11464331.
DOI: 10.3389/fimmu.2024.1469829.
Identification of a transcription factor network regulating anti-TNF mediated expression in human CD4+ T cells.
Povoleri G, Ridley M, Marrow R, Lalnunhlimi S, Ryan S, Kelly A
Discov Immunol. 2024; 3(1):kyae013.
PMID: 39290825
PMC: 11407445.
DOI: 10.1093/discim/kyae013.
Novel insights: crosstalk with non-puerperal mastitis and immunity.
Zhou Y, Gong J, Deng X, Shen L, Liu L
Front Immunol. 2024; 15:1431681.
PMID: 39148739
PMC: 11324573.
DOI: 10.3389/fimmu.2024.1431681.
Guselkumab Reduces Disease- and Mechanism-Related Biomarkers More Than Adalimumab in Patients with Psoriasis: A VOYAGE 1 Substudy.
Blauvelt A, Langley R, Branigan P, Liu X, Chen Y, DePrimo S
JID Innov. 2024; 4(5):100287.
PMID: 39114670
PMC: 11305298.
DOI: 10.1016/j.xjidi.2024.100287.
Parsing patterns: Emerging roles of tissue self-organization in health and disease.
Ramos R, Swedlund B, Ganesan A, Morsut L, Maini P, Monuki E
Cell. 2024; 187(13):3165-3186.
PMID: 38906093
PMC: 11299420.
DOI: 10.1016/j.cell.2024.05.016.
TAZ deficiency exacerbates psoriatic pathogenesis by increasing the histamine-releasing factor.
Song J, Kim H, Cho H, Yoon S, Lim J, Lee K
Cell Biosci. 2024; 14(1):60.
PMID: 38734624
PMC: 11088771.
DOI: 10.1186/s13578-024-01246-0.
The Immunology of Psoriasis-Current Concepts in Pathogenesis.
Sieminska I, Pieniawska M, Grzywa T
Clin Rev Allergy Immunol. 2024; 66(2):164-191.
PMID: 38642273
PMC: 11193704.
DOI: 10.1007/s12016-024-08991-7.
3,3'-Diindolylmethane inhibits Th17 cell differentiation via impairing IRF-7-mediated plasmacytoid dendritic cell activation in imiquimod-induced psoriasis mice.
Rasool M, Srikanth M, Rithvik A
In Vitro Cell Dev Biol Anim. 2024; 60(6):678-688.
PMID: 38602626
DOI: 10.1007/s11626-024-00901-7.
Association of IL-17F rs763780 polymorphism and risk of psoriasis in Turkish population: a case-control study.
Akadam-Teker A, Aksan B
An Bras Dermatol. 2024; 99(3):357-361.
PMID: 38331704
PMC: 11074563.
DOI: 10.1016/j.abd.2023.06.006.
A Systematic Review of Interleukin-17 in Oral Lichen Planus: From Etiopathogenesis to Treatment.
Agha-Hosseini F, Moosavi M, Bahrami H
Clin Med Res. 2024; 21(4):201-215.
PMID: 38296640
PMC: 11149959.
DOI: 10.3121/cmr.2023.1822.
Exosomes released by environmental pollutant-stimulated Keratinocytes/PBMCs can trigger psoriatic inflammation in recipient cells via the AhR signaling pathway.
Kim H, Lee S, You G, Park C, Kim H, Chung B
Front Mol Biosci. 2024; 10:1324692.
PMID: 38288335
PMC: 10822922.
DOI: 10.3389/fmolb.2023.1324692.
Histological and functional characterization of 3D human skin models mimicking the inflammatory skin diseases psoriasis and atopic dermatitis.
Scheurer J, Sauer B, Focken J, Giampetraglia M, Jager A, Schurch C
Dis Model Mech. 2024; 17(1).
PMID: 38251799
PMC: 10846593.
DOI: 10.1242/dmm.050541.
CD1a and skin T cells: a pathway for therapeutic intervention.
Ye J, Chen Y, Ogg G
Clin Exp Dermatol. 2024; 49(5):450-458.
PMID: 38173286
PMC: 11037390.
DOI: 10.1093/ced/llad460.